TAURUS MEDICAL SOLUTIONS LIMITEDActive

Company number 06702207Private limited companyIncorporated 2008

Key figures

£835,565+25.7%
Net assets 2024/25
+9.9%
Average annual growth 2021/22–2024/25
0250 k500 k750 k1 m2021/222022/232024/25

Like most small UK companies, TAURUS MEDICAL SOLUTIONS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2021/222022/232024/25
Filed accounts2021/22–2024/25
2021/222022/232024/25
Cash at bank and in hand1,096,917887,6081,028,598
Total assets1,207,9491,151,3341,313,553
Total liabilities517,532490,335483,363
Net assets / total equity691,788664,563835,565
Average number of employees222

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: TAURUS MEDICAL SOLUTIONS LIMITED

Company

TAURUS MEDICAL SOLUTIONS LIMITED is a private limited company registered with Companies House under company number 06702207. It was incorporated on 18 Sep 2008. Its status is active. The registered office is in Cannock (WS11). Its nature of business (SIC 2007) is retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Sep 2025); the company files abridged accounts (unaudited). Net assets were £835,565, up 25.7% on the previous year. Cash at bank and in hand was £1,028,598. Total assets were £1,313,553 and total liabilities £483,363. The company had an average of 2 employees. Figures are available for 3 financial years (2021/22–2024/25).

Control and charges

One person with significant control is registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Jun 2027. The next confirmation statement is due by 2 Oct 2027.